MCRB Competitors & Alternatives
Compare Seres Therapeutics Inc with similar stocks in the same industry
Biotechnology
MCRB
Main Stock$6.81
Tradestie Score
53
Market Cap
$179.47M
Revenue Growth
-0.9%
Analyst Upside
+149.6%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ACHV
Achieve Life Sciences, Inc.
|
$5.30
|
$158.43M | - | 52 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$24.48
|
$154.27M | - | 58 | Compare |
|
FATE
Fate Therapeutics, Inc.
|
$2.06
|
$144.16M | - | 56 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$12.75
|
$133.50M | - | 66 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$6.01
|
$114.01M | - | 55 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$24.91
|
$110.20M | - | 61 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$6.51
|
$71.69M | - | 58 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$10.04
|
$67.94M | - | 59 | Compare |
|
KPTI
Karyopharm Therapeutics Inc.
|
$9.12
|
$53.85M | - | 55 | Compare |
|
SYRS
SYRS
|
- | - | - | - | Compare |
More MCRB Analysis
Data updated: Jun 24, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry